High-resolution HLA typing by long reads from the R10.3 Oxford nanopore flow cellsHUMAN IMMUNOLOGYIF2.22021-04-0130PREAI
Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty A Randomized Clinical TrialJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552019-09-0310OAAI
Gamma-glutamyl carboxylase and its influence on warfarin doseTHROMBOSIS AND HAEMOSTASISIF4.32017-11-2451OAAI
Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty The GIFT Randomized Clinical TrialJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552017-09-26194OAAI
A Polymorphism in the VKORC1 Regulator Calumenin Predicts Higher Warfarin Dose Requirements in African AmericansCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52010-03-0388OAAI
Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patientsJOURNAL OF THROMBOSIS AND HAEMOSTASISIF52008-10-0184OAAI
Soluble CD40 ligand measurement inaccuracies attributable to specimen type, processing time, and ELISA methodCLINICAL CHEMISTRYIF6.32005-06-0134OAAI
Definition of a factor Va binding site in factor XaJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92001-02-0154OAAI
Directed glycosylation of human coagulation factor X at residue 333 - Insight into factor Va-dependent prothrombin catalysisJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92000-12-0111OAAI
Factor X(St Louis II) - Identification of a glycine substitution at residue 7 and characterization of the recombinant proteinJOURNAL OF BIOLOGICAL CHEMISTRYIF3.91996-11-0136OAAI